This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ANI Pharmaceuticals (ANIP) Catches Eye: Stock Jumps 17.7%
by Zacks Equity Research
ANI Pharmaceuticals (ANIP) shares rose nearly 18% in the last trading session, amid huge volumes.
Moving Average Crossover Alert: ANI Pharmaceuticals (ANIP)
by Zacks Equity Research
ANI Pharmaceuticals, Inc. (ANIP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
New Strong Buy Stocks for August 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
This Value Screen Is Our Top Performer This Year
by Kevin Matras
See how this screen has blown past the market and how you can start using it in your own portfolio. Highlighted stocks include ANIP, KCG, MDR, POWL and RRMS.
5 Stocks With Incredible Growth Prospects
by Brian Bolan
A screen for 35% or more growth in revenue and earnings results in these picks!